
### [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952)
**Label:** Hodgkins lymphoma

**Subclasses:** [MONDO:0020328](http://purl.obolibrary.org/obo/MONDO_0020328) (classic Hodgkin lymphoma, mixed cellularity type), [MONDO:0020329](http://purl.obolibrary.org/obo/MONDO_0020329) (classic Hodgkin lymphoma, lymphocyte-rich type), [MONDO:0019478](http://purl.obolibrary.org/obo/MONDO_0019478) (nodular lymphocyte predominant Hodgkin lymphoma), [MONDO:0010273](http://purl.obolibrary.org/obo/MONDO_0010273) (lymphoma, Hodgkin, X-linked pseudoautosomal), [MONDO:0020330](http://purl.obolibrary.org/obo/MONDO_0020330) (classic Hodgkin lymphoma, lymphocyte-depleted type), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0010762](http://purl.obolibrary.org/obo/MONDO_0010762) (lymphoma, Hodgkin, Y-linked pseudoautosomal), [MONDO:0020327](http://purl.obolibrary.org/obo/MONDO_0020327) (classic Hodgkin lymphoma, nodular sclerosis type), 

**Corr. equiv. classes:** [OMIM:300221](http://purl.obolibrary.org/obo/OMIM_300221), [Orphanet:98843](http://www.orpha.net/ORDO/Orphanet_98843), [Orphanet:98844](http://www.orpha.net/ORDO/Orphanet_98844), [Orphanet:98845](http://www.orpha.net/ORDO/Orphanet_98845), [Orphanet:391](http://www.orpha.net/ORDO/Orphanet_391), [Orphanet:98846](http://www.orpha.net/ORDO/Orphanet_98846), [OMIM:400021](http://purl.obolibrary.org/obo/OMIM_400021), [Orphanet:86893](http://www.orpha.net/ORDO/Orphanet_86893), [OMIM:236000](http://purl.obolibrary.org/obo/OMIM_236000), 

**Class expressions from DL-Learner:**

- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) 29.44%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 28.56%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 27.75%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) 27.02%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 26.12%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 23.37%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 19.60%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 19.46%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 18.93%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 18.93%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 18.65%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 18.33%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 17.55%
- Thing 17.55%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 17.55%


